GENINCODE PLC — Investor Relations & Filings
GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-08 | English | |
| Grant of Share Options & PDMR Dealings | 2026-05-07 | English | |
| Holding(s) in Company | 2026-02-26 | English | |
| Holding(s) in Company | 2026-02-24 | English | |
| Holding(s) in Company | 2026-02-12 | English | |
| Holding(s) in Company | 2026-02-12 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 44302284 | Holding(s) in Company | 2026-05-08 | English | ||
| 42453279 | Grant of Share Options & PDMR Dealings | 2026-05-07 | English | ||
| 32843679 | Holding(s) in Company | 2026-02-26 | English | ||
| 34563216 | Holding(s) in Company | 2026-02-24 | English | ||
| 19467055 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466908 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466858 | Holding(s) in Company | 2026-02-12 | English | ||
| 18247395 | Result of GM, Director Shareholdings and TVR | 2026-02-09 | English | ||
| 14783432 | Additional Subscription | 2026-02-06 | English | ||
| 13343227 | Result of Retail Offer | 2026-01-26 | English | ||
| 13199807 | Result of Placing and Subscription | 2026-01-22 | English | ||
| 13159849 | Retail Offer | 2026-01-21 | English | ||
| 13159846 | Placing and Subscription | 2026-01-21 | English | ||
|
2025
2 filings
| |||||
| 10225432 | Collaboration with Sohin Genetics | 2025-12-17 | English | ||
| 9627671 | Holding(s) in Company | 2025-12-08 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GENINCODE PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SYNTARA LIMITED
Clinical-stage developer of small molecule drugs for inflam…
|
SNT | AU | Professional, scientific and te… |
|
SyntekaBio,Inc.
An AI-driven drug discovery company using supercomputing to…
|
226330 | KR | Professional, scientific and te… |
|
Take Solutions Ltd
Provides specialized domain-led technology and services for…
|
TAKE | IN | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
GENINCODE PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7669/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7669 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7669 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7669 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7669}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENINCODE PLC (id: 7669)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.